AUTHERINE STERLING: Open Payments
NPI 1053847335 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$582 in 26 payments from 10 companies in 2025. Trend: 2023 $98 · 2024 $24 · 2025 $582
Food & beverage: $582
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $141 |
| Ardelyx, Inc. | 4 | $81 |
| Lilly USA, LLC | 3 | $78 |
| GENZYME CORPORATION | 2 | $58 |
| Tactile Systems Technology Inc | 1 | $54 |
| Phathom Pharmaceuticals, Inc. | 3 | $50 |
| QOL Medical, LLC | 2 | $48 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| Ipsen Biopharmaceuticals, Inc | 1 | $21 |
| Organon LLC | 1 | $14 |
Products named: TREMFYA, DUPIXENT, IBSRELA, OMVOH, Flexitouch Plus, VOQUEZNA, Sucraid, IQIRVO.
Industry payments across DE — which companies pay providers there.
